Dietary changes for kidney health in polycystic kidney disease
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a specific diet can lower a marker of inflammation in the urine, which may help slow kidney damage in people with autosomal dominant polycystic kidney disease (ADPKD).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have ADPKD, confirmed by a doctor or genetic testing.
- Your kidney function is moderately reduced (eGFR between 45 and 90).
- Your kidney size and structure fit a certain pattern (Mayo class 1C-1E).
- Your kidney function has been stable for the last 3 months.
- You are willing to follow a specific diet and not use certain medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether following a special diet for one week can help people with polycystic kidney disease. It aims to see if the diet is safe and if it can slow down the disease.
This study tests a special medical food (Ren-Nu) to see if it helps with metabolism and kidney health in people with ADPKD. You would follow a dietary program and attend online classes.
This study follows patients with a genetic kidney disease (autosomal dominant polycystic kidney disease) who are on dialysis and receive a procedure to block blood flow to their enlarged kidneys. Researchers will track how well the procedure works and how it affects patients over time using imaging scans.
This study tests whether a ketogenic diet can slow the progression of polycystic kidney disease in adults who are at risk for rapid decline. You'll follow a carefully planned low-carb, high-fat diet to see if it helps protect your kidneys.
This study enrolls adults with autosomal dominant polycystic kidney disease (ADPKD) to better understand the disease and its related changes in the body. It may help researchers find improved ways to track the condition and support future treatments.
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
Hear when a new Autosomal Dominant Polycystic Kidney Disease (ADPKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.